• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

The Hydropothecary Corporation Receives Cannabis Oils License

March 29, 2017


GATINEAU, QC--(Marketwired - March 29, 2017) - The Hydropothecary Corporation (TSX VENTURE: THCX) (the "Company"), a licensed producer and distributor of medical cannabis, is pleased to announce it has received an amendment to its licence from Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada) (the "ACMPR") to include the sale of cannabis oils from its facility in Gatineau, QC. The Company's license under the ACMPR was amended from production only and provides the Company with the ability to sell cannabis oil products to registered patients under the ACMPR along with its current dried medical cannabis products.


The Company received an amendment to its licence under the ACMPR to produce cannabis oils in August 2015 and has been focused on the development of a new innovative oil product line. In anticipation of this approval to sell cannabis oil extracts, the Company has been producing cannabis oil and extracts. Sales are anticipated to begin late Spring 2017.


"This is another significant milestone in the Hydropothecary growth story and provides our clients with yet another way in which to consume their medicinal cannabis without smoking" said Sebastien St-Louis, Co-Founder and Chief Executive Officer.


About The Hydropothecary Corporation


The Hydropothecary Corporation is an authorized licensed producer and distributor of medical marijuana licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada). Hydropothecary provides naturally grown and rigorously tested medical marijuana of uncompromising quality. Hydropothecary's branding, marijuana product offering, patient service standards and product pricing are consistent with THC's positioning as a premium brand for a legal source for medical marijuana within this new marketplace. In addition to medical marijuana production and sales, Hydropothecary explores various research and development opportunities for cannabinoid extracts, drugs and combinatory chemistry. In addition, the company is investigating the development and patenting of novel technologies related to medical marijuana, as well as the import and export of medical marijuana.


Forward-Looking Information


This press release contains forward-looking information based on current expectations.

Statements about market making activities and TSXV approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.